Concepedia

Author

H.W.A. de Bruijn

University of Groningen

Also Known As

H W A de Bruijn, H. W. A. DE BRUIJN, H. W. A. De Bruijn, H. W. A. de BRUIJN, H. W. A. de Bruijn, H. W.A. de Bruijn, H.W.A. BRUIJN, H.W.A. DE BRUIJN, H.W.A. De Bruijn, H.W.A. de Bruijn

75

Publications

3.7K

Citations

26

H-Index

75

Concepts

All Affiliations

University of GroningenUniversity Medical Center GroningenLeiden UniversityThe University of Texas MD Anderson Cancer CenterDuke Medical Center
HD

About

H.W.A. de Bruijn is an author at University of Groningen specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

23

1.4K

2

Public Health

6

6

226

3

Health Sciences

2

2

44

4

Engineering

1

1

122

5

Cell Biology

1

1

13

H.W.A. de Bruijn

×

47

Publications

3.6K

Citations

26

H-Index

YearCitations

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

Zhen Zhang, Robert C. Bast, Yinhua Yu,

Cancer Research

2004

947

Inhibin as a Marker for Granulosa-Cell Tumors

Richard E. Lappöhn, Henry Burger, J. Bouma,

New England Journal of Medicine

1989

322

Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal Distributions

Steven J. Skates, Nora Horick, Yinhua Yu,

Journal of Clinical Oncology

2004

179

CA 125: A useful marker in endometrial carcinoma

Jitze M. Duk, Jan G. Aalders, Gert Jan Fleuren,

American Journal of Obstetrics and Gynecology

1986

172

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

Zhen Zhang, Yinhua Yu, Fengji Xu,

Gynecologic Oncology

2007

157

Specificity and Affinity of 26 Monoclonal Antibodies against the CA 125 Antigen: First Report from the ISOBM TD-1 Workshop

Kjell Nustad, Robert C. Bast, Timothy J. O rsquo Brien,

Tumor Biology

1996

134

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

M.J.A. Engelen, H.W.A. de Bruijn, Harrie Hollema,

Gynecologic Oncology

2000

133

Sample preparation of human serum for the analysis of tumor markers

Natalia Govorukhina, A. Keizer-Gunnink, Ate G.J. van der Zee,

Journal of Chromatography A

2003

122

OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma

Carolien van Haaften-Day, Yu Shen, Fengji Xu,

Cancer

2001

110

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

Gert Jan Fleuren, Marius Nap, Jan G. Aalders,

Cancer

1987

99

Page 1